Sponsor Pipeline

Charles LeMoyne Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06855589 Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer… Prostate Cancer (Adenocarcinoma) Not Yet Recruiting
Not specified
NCT07478315 IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer… Breast Cancer Not Yet Recruiting
Disease Areas
Prostate Cancer (1) Breast Cancer (1)
Get alerts when Charles LeMoyne Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free